Literature DB >> 29855847

Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats.

Luciele Varaschini Teixeira1, Roberto Farina Almeida2, Francieli Rohden2, Leo Anderson Meira Martins2, Poli Mara Spritzer3, Diogo Onofre Gomes de Souza2.   

Abstract

Guanosine (GUO) has neuroprotective effects in experimental models of brain diseases involving glutamatergic excitotoxicity in male animals; however, its effects in female animals are poorly understood. Thus, we investigated the influence of gender and GUO treatment in adult male and female Wistar rats submitted to focal permanent cerebral ischemia in the motor cortex brain. Female rats were subdivided into non-estrogenic and estrogenic phase groups by estrous cycle verification. Immediately after surgeries, the ischemic animals were treated with GUO or a saline solution. Open field and elevated plus maze tasks were conducted with ischemic and naïve animals. Cylinder task, immunohistochemistry and infarct volume analyses were conducted only with ischemic animals. Female GUO groups achieved a full recovery of the forelimb symmetry at 28-35 days after the insult, while male GUO groups only partially recovered at 42 days, in the final evaluation. The ischemic insult affected long-term memory habituation to novelty only in female groups. Anxiety-like behavior, astrocyte morphology and infarct volume were not affected. Regardless the estrous cycle, the ischemic injury affected differently female and male animals. Thus, this study points that GUO is a potential neuroprotective compound in experimental stroke and that more studies, considering the estrous cycle, with both genders are recommended in future investigation concerning brain diseases.

Entities:  

Keywords:  Estrous cycle; Female; Immunohistochemistry; Ischemic stroke; Open field test; Symmetry

Mesh:

Substances:

Year:  2018        PMID: 29855847     DOI: 10.1007/s11064-018-2562-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  96 in total

1.  Characterization of anxiety and habituation profile following global ischemia in rats.

Authors:  Hélène Plamondon; Samir Khan
Journal:  Physiol Behav       Date:  2005-03-31

2.  Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.

Authors:  G F Cittolin-Santos; A M de Assis; P A Guazzelli; L G Paniz; J S da Silva; M E Calcagnotto; G Hansel; K C Zenki; E Kalinine; M M Duarte; D O Souza
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

3.  Temporal Trends in Sex Differences With Regard to Stroke Incidence: The Dijon Stroke Registry (1987-2012).

Authors:  Marie Giroud; Benoit Delpont; Benoit Daubail; Christelle Blanc; Jérôme Durier; Maurice Giroud; Yannick Béjot
Journal:  Stroke       Date:  2017-03-08       Impact factor: 7.914

Review 4.  Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior.

Authors:  Michael M Halassa; Philip G Haydon
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

5.  Protective effects of guanosine against sepsis-induced damage in rat brain and cognitive impairment.

Authors:  Fabricia Petronilho; Susane Raquel Périco; Francieli Vuolo; Francielle Mina; Larissa Constantino; Clarissa M Comim; João Quevedo; Diogo Onofre Souza; Felipe Dal-Pizzol
Journal:  Brain Behav Immun       Date:  2012-04-04       Impact factor: 7.217

6.  Protective activity of guanosine in an in vitro model of Parkinson's disease.

Authors:  P Giuliani; S Romano; P Ballerini; R Ciccarelli; N Petragnani; S Cicchitti; M Zuccarini; S Jiang; M P Rathbone; F Caciagli; P Di Iorio
Journal:  Panminerva Med       Date:  2012-12       Impact factor: 5.197

7.  Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions.

Authors:  Tharine Dal-Cim; Fabiana K Ludka; Wagner C Martins; Charlise Reginato; Esther Parada; Javier Egea; Manuela G López; Carla I Tasca
Journal:  J Neurochem       Date:  2013-06-17       Impact factor: 5.372

8.  Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.

Authors:  Louise Lind Schierbeck; Lars Rejnmark; Charlotte Landbo Tofteng; Lis Stilgren; Pia Eiken; Leif Mosekilde; Lars Køber; Jens-Erik Beck Jensen
Journal:  BMJ       Date:  2012-10-09

9.  Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine.

Authors:  Diogo Losch de Oliveira; Joel Felipe Horn; Juliana Moura Rodrigues; Marcos E S Frizzo; Emílio Moriguchi; Diogo Onofre Souza; Susana Wofchuk
Journal:  Brain Res       Date:  2004-08-20       Impact factor: 3.252

Review 10.  NIH initiative to balance sex of animals in preclinical studies: generative questions to guide policy, implementation, and metrics.

Authors:  Louise D McCullough; Geert J de Vries; Virginia M Miller; Jill B Becker; Kathryn Sandberg; Margaret M McCarthy
Journal:  Biol Sex Differ       Date:  2014-10-03       Impact factor: 5.027

View more
  3 in total

Review 1.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

2.  Functional Recovery Caused by Human Adipose Tissue Mesenchymal Stem Cell-Derived Extracellular Vesicles Administered 24 h after Stroke in Rats.

Authors:  Francieli Rohden; Luciele Varaschini Teixeira; Luis Pedro Bernardi; Pamela Cristina Lukasewicz Ferreira; Mariana Colombo; Geciele Rodrigues Teixeira; Fernanda Dos Santos de Oliveira; Elizabeth Obino Cirne Lima; Fátima Costa Rodrigues Guma; Diogo Onofre Souza
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

3.  Repeatability analysis improves the reliability of behavioral data.

Authors:  Juliane Rudeck; Silvia Vogl; Stefanie Banneke; Gilbert Schönfelder; Lars Lewejohann
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.